Abstract
Purpose
The authors compared definitive intensity-modulated radiotherapy (IMRT) with definitive conventional radiotherapy (2D-RT) in cervical oesophageal squamous cell carcinoma (CESCC).
Materials and methods
A total of 101 patients with CESCC treated with definitive radiotherapy from January 2001 to April 2012 were analysed. 37 patients were irradiated using 2D-RT, whereas 64 cases were treated using IMRT.
Results
The median follow-up time was 15.5 months for all the patients. For all patients, the overall 2-year local failure-free survival (LFFS), regional failure-free survival (RFFS), and overall survival (OS) rate was 67.4, 85.2 and 46.2 %, respectively. The 2-year LFFS rate and the 2-year RFFS rate in the IMRT group were higher than the 2D-RT group, although no statistically significant difference was observed in LFFS and RFFS. No statistically significant difference was observed in overall survival (OS) between the groups. Compared with 2D-RT, the rate of grade 3 dysphagia after radiotherapy was lower (6.3 vs. 8.1 %) and none had hypothyroidism requiring lifelong thyroxine replacement in the IMRT group. Matched-cases analysis did not show a statistical difference in terms of LFFS, RFFS and OS between the groups.
Conclusions
Although no statistically significant difference was observed in OS, LFFS and RFFS between the IMRT group and the 2D-RT group, the incidence of late toxicity declined using IMRT, thereby resulting in an improved therapeutic ratio for patients with CESCC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mendenhall WM, Sombeck MD, Parsons JT et al (1994) Management of cervical esophageal carcinoma. Semin Radiat Oncol 4:179–191
Mendenhall WM, Parsons JT, Vogel SB et al (1988) Carcinoma of the cervical esophagus treated with radiation therapy. Laryngoscope 98:769–771
Stuschke M, Stahl M, Wilke H et al (1999) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical esophagus. Oncology 57:99–105
Burmeister BH, Dickie G, Smithers BM et al (2000) Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 126:205–208
Yamada K, Murakami M, Okamoto Y et al (2006) Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol 45(8):1120–1125
Wang S, Liao Z, Chen Y et al (2006) Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single- institution experience. J Thorac Oncol 1(3):252–259
Huang SH, Lockwood G, Brierley J et al (2008) Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys 71(3):735–740
Grass GD, Cooper SL, Armeson K et al (2014) Cervical esophageal cancer: a population-based study. Head Neck. doi:10.1002/hed.23678
Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174
Zhang Z, Liao Z, ** J et al (2005) Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:656–664
Okawa T, Dokiya T, Nishio M et al (1999) Multiinstitutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan: Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys 45:623–628
Fenkell L, Kaminsky I, Breen S et al (2008) Dosimetric comparison of IMRT vs 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 89:287–291
Wang L, Han C, Zhu SC et al (2006) Dosimetry study on conventional and three dimensional conformal radiotherapy for esophageal cancer. Chin J Radiat Oncol 15(3):176–180
Wang SL, Liao Z, Liu H et al (2006) Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12:5501–5508
Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326(24):1593–1598
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346
Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127–136
Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627
Yi JL, Gao L, Xu ZG et al (2011) Phase III study of preoperative concurrent chemoradiotherapy compared with preoperative radiotherapy alone in the treatment of locally advanced head and neck squamous cell carcinoma. Chin J Radiat Oncol 20(5):363–367
Feng FY, Kim HM, Lyden TH et al (2010) Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 28(16):2732–2738
Logemann JA, Pauloski BR, Rademaker AW et al (2008) Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30:148–158
Gillespie MB, Brodsky MB, Day TA et al (2005) Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 131:615–619
Hancock SB, Krempl GA, Canfield V et al (2008) Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy. Laryngoscope 118:1357–1361
Shiley SG, Hargunani CA, Skoner JM et al (2006) Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134:455–459
Machtay M, Rosenthal DI, Hershock D et al (2002) Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. J Clin Oncol 20:3964–3971
Rancati T, Schwarz M, Allen AM et al (2010) Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 76(3 Suppl):S64–S69
Acknowledgments
Funding by Health and Medical Development Foundation of China (2009-05) to **gwei Luo.
Conflict of interest
The authors declare that they have no conflict of interest to the publication of this article.
